Gabapentin decreases epileptiform discharges in a chronic model of neocortical trauma

被引:55
作者
Li, Huifang [1 ]
Graber, Kevin D. [1 ]
Jin, Sha [1 ]
McDonald, Whitney [1 ]
Barres, Ben A. [2 ]
Prince, David A. [1 ]
机构
[1] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA
[2] Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA
关键词
Gabapentin; Posttraumatic epileptiform activity; Synapse formation; EPSCs; GFAP; Gliosis; Neocortex; TSPs; Alpha2delta1; subunit; Fluoro-Jade C; PROPHYLACTICALLY ADMINISTERED PHENYTOIN; CALCIUM-CHANNEL SUBUNIT; V PYRAMIDAL NEURONS; FLUORO-JADE; SYNAPTIC REORGANIZATION; POSTTRAUMATIC SEIZURES; NEUROPATHIC PAIN; UP-REGULATION; BRAIN-INJURY; CA2+ INFLUX;
D O I
10.1016/j.nbd.2012.06.019
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Gabapentin (GBP) is an anticonvulsant that acts at the alpha 2 delta-1 submit of the L-type calcium channel. It is recently reported that GBP is a potent inhibitor of thrombospondin (TSP)-induced excitatory synapse formation in vitro and in vivo. Here we studied effects of chronic GBP administration on epileptogenesis in the partial cortical isolation ("undercut") model of posttraumatic epilepsy, in which abnormal axonal sprouting and aberrant synaptogenesis contribute to occurrence of epileptiform discharges. Results showed that 1) the incidence of evoked epileptiform discharges in undercut cortical slices studied 1 day or similar to 2 weeks after the last GBP dose, was significantly reduced by GBP treatments, beginning on the day of injury; 2) the expression of GFAP and TSP1 protein, as well as the number of FJC stained cells was decreased in GBP treated undercut animals; 3) in vivo GBP treatment of rats with undercuts for 3 or 7 days decreased the density of vGlut1-PSD95 close appositions (presumed synapses) in comparison to saline treated controls with similar lesions;4) the electrophysiological data are compatible with the above anatomical changes, showing decreases in mEPSC and sEPSC frequency in the GBP treated animals. These results indicate that chronic administration of GBP after cortical injury is antiepileptogenic in the undercut model of post-traumatic epilepsy, perhaps by both neuroprotective actions and decreases in excitatory synapse formation. The findings may suggest the potential use of GBP as an antiepileptogenic agent following traumatic brain injury. (c) 2012 Elsevier Inc. All rights reserved.
引用
收藏
页码:429 / 438
页数:10
相关论文
共 96 条
[1]   A population-based study of seizures after traumatic brain injuries [J].
Annegers, JF ;
Hauser, WA ;
Coan, SP ;
Rocca, WA .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (01) :20-24
[2]   SYNAPTIC REORGANIZATION BY MOSSY FIBERS IN HUMAN EPILEPTIC FASCIA-DENTATA [J].
BABB, TL ;
KUPFER, WR ;
PRETORIUS, JK ;
CRANDALL, PH ;
LEVESQUE, MF .
NEUROSCIENCE, 1991, 42 (02) :351-363
[3]  
BABB TL, 1992, DENDRON, V1, P7
[4]   The Increased Trafficking of the Calcium Channel Subunit α2δ-1 to Presynaptic Terminals in Neuropathic Pain Is Inhibited by the α2δ Ligand Pregabalin [J].
Bauer, Claudia S. ;
Nieto-Rostro, Manuela ;
Rahman, Wahida ;
Tran-Van-Minh, Alexandra ;
Ferron, Laurent ;
Douglas, Leon ;
Kadurin, Ivan ;
Ranjan, Yorain Sri ;
Fernandez-Alacid, Laura ;
Millar, Neil S. ;
Dickenson, Anthony H. ;
Lujan, Rafael ;
Dolphin, Annette C. .
JOURNAL OF NEUROSCIENCE, 2009, 29 (13) :4076-4088
[5]   Novel role for gabapentin in neuroprotection of central nervous system in streptozotocine-induced diabetic rats [J].
Baydas, G ;
Sonkaya, E ;
Tuzcu, M ;
Yasar, A ;
Donder, E .
ACTA PHARMACOLOGICA SINICA, 2005, 26 (04) :417-422
[6]   Gabapentin may inhibit synaptic transmission in the mouse spinal cord dorsal horn through a preferential block of P/Q-type Ca2+ channels [J].
Bayer, K ;
Ahmadi, S ;
Zeilhofer, HU .
NEUROPHARMACOLOGY, 2004, 46 (05) :743-749
[7]   Gabapentin actions on Kir3 currents and N-type Ca2+ channels via GABAB receptors in hippocampal pyramidal cells [J].
Bertrand, S ;
Nouel, D ;
Morin, F ;
Nagy, F ;
Lacaille, JC .
SYNAPSE, 2003, 50 (02) :95-109
[8]   Is pharmacological neuroprotection dependent on reduced glutamate release? [J].
Calabresi, P ;
Picconi, B ;
Saulle, E ;
Centonze, D ;
Hainsworth, AH ;
Bernardi, G .
STROKE, 2000, 31 (03) :766-772
[9]  
Carmichael ST, 2002, J NEUROSCI, V22, P6062
[10]  
CERVOSNAVARRO J, 1991, J NEUROL SCI, V103, pS3